Tyramine fragment binding to BACE-1
Kuglstatter, A., Stahl, M., Peters, J.U., Huber, W., Stihle, M., Schlatter, D., Benz, J., Ruf, A., Roth, D., Enderle, T., Hennig, M.(2008) Bioorg Med Chem Lett 18: 1304-1307
- PubMed: 18226904 
- DOI: https://doi.org/10.1016/j.bmcl.2008.01.032
- Primary Citation of Related Structures:  
3BRA, 3BUF, 3BUG, 3BUH - PubMed Abstract: 
Fragment screening revealed that tyramine binds to the active site of the Alzheimer's disease drug target BACE-1. Hit expansion by selection of compounds from the Roche compound library identified tyramine derivatives with improved binding affinities as monitored by surface plasmon resonance. X-ray structures show that the amine of the tyramine fragment hydrogen-bonds to the catalytic water molecule. Structure-guided ligand design led to the synthesis of further low molecular weight compounds that are starting points for chemical leads.
Organizational Affiliation: 
F. Hoffmann-La Roche, Pharma Research Basel, Grenzacherstr., 4070 Basel, Switzerland.